Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancer.
Takeda T, Tin AL, Corradi RB, Alvim R, Hashimoto T, Ito Y, Nguyen DP, Mamoor M, Robertson NL, Vargas HA, Benfante NE, Sjoberg DD, Eastham JA, Scardino PT, Fine SW, Oya M, Touijer KA.
Takeda T, et al.
Int J Urol. 2020 Feb;27(2):179-185. doi: 10.1111/iju.14161. Epub 2019 Dec 13.
Int J Urol. 2020.
PMID: 31833113
Free PMC article.